000 | 01929 a2200517 4500 | ||
---|---|---|---|
005 | 20250517034938.0 | ||
264 | 0 | _c20160307 | |
008 | 201603s 0 0 eng d | ||
022 | _a1946-6242 | ||
024 | 7 |
_a10.1126/scitranslmed.aaa4549 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEvans, Brian C | |
245 | 0 | 0 |
_aMK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasia. _h[electronic resource] |
260 |
_bScience translational medicine _cJun 2015 |
||
300 |
_a291ra95 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aEndocytosis _xdrug effects |
650 | 0 | 4 |
_aEndosomes _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aHyperplasia |
650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aLysosomes _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocytes, Smooth Muscle _xdrug effects |
650 | 0 | 4 |
_aNanoparticles _xchemistry |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aSaphenous Vein _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTunica Intima _xdrug effects |
650 | 0 | 4 | _aVascular Grafting |
700 | 1 | _aHocking, Kyle M | |
700 | 1 | _aOsgood, Michael J | |
700 | 1 | _aVoskresensky, Igor | |
700 | 1 | _aDmowska, Julia | |
700 | 1 | _aKilchrist, Kameron V | |
700 | 1 | _aBrophy, Colleen M | |
700 | 1 | _aDuvall, Craig L | |
773 | 0 |
_tScience translational medicine _gvol. 7 _gno. 291 _gp. 291ra95 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1126/scitranslmed.aaa4549 _zAvailable from publisher's website |
999 |
_c24970708 _d24970708 |